The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Black Stone Minerals | Common | 09225M101 | 37,122 | 5,711,137 | SH | SOLE | 5,711,137 | 0 | 0 | ||
| Unity Biotechnology Inc | Common | 91381U101 | 13,645 | 1,571,981 | SH | SOLE | 1,571,981 | 0 | 0 | ||
| Evelo Bioseciences Inc | Common | 299734103 | 2,376 | 484,953 | SH | SOLE | 484,953 | 0 | 0 | ||
| Biosig Tech Inc | Common | 09073N201 | 1,126 | 156,384 | SH | SOLE | 156,384 | 0 | 0 | ||
| Seres Therapeutics Inc | Common | 81750R102 | 857 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
| Clearpoint Neuro Inc (fka MRI INTERVENTIONS INC) | Common | 18507C103 | 168 | 47,148 | SH | SOLE | 47,148 | 0 | 0 | ||
| CANCER GENETICS INC | Common | 13739U203 | 1 | 444 | SH | SOLE | 444 | 0 | 0 | ||
| SPDR ETF | Common | 78462F103 | 27,964 | 90,686 | SH | SOLE | 90,686 | 0 | 0 | ||
| Zentalis Pharmaceuticals Inc | Common | 98943L107 | 21,259 | 442,713 | SH | SOLE | 442,713 | 0 | 0 | ||